ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 97 filers reported holding ENZO BIOCHEM INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $62,000 | +100.0% | 30,133 | +147.4% | 0.01% | +66.7% |
| Q4 2020 | $31,000 | +24.0% | 12,182 | +8.8% | 0.00% | 0.0% |
| Q2 2020 | $25,000 | -84.6% | 11,194 | -76.7% | 0.00% | -66.7% |
| Q2 2019 | $162,000 | +194.5% | 48,036 | +262.9% | 0.01% | +200.0% |
| Q3 2018 | $55,000 | -3.5% | 13,237 | +28.3% | 0.00% | 0.0% |
| Q1 2018 | $57,000 | -73.1% | 10,321 | -49.1% | 0.00% | -70.0% |
| Q3 2017 | $212,000 | – | 20,263 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |